Tri Locum Partners as of March 31, 2024
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 27 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 10.8 | $31M | 2.2M | 14.11 | |
| Avadel Pharmaceuticals Sponsored Adr | 7.0 | $20M | 1.2M | 16.89 | |
| Silk Road Medical Inc Common | 6.9 | $20M | 1.1M | 18.32 | |
| Natera (NTRA) | 6.0 | $17M | 190k | 91.46 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 5.9 | $17M | 113k | 151.17 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 5.5 | $16M | 284k | 56.09 | |
| Merck & Co (MRK) | 5.5 | $16M | 119k | 131.95 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.2 | $15M | 36k | 418.01 | |
| Madrigal Pharmaceuticals (MDGL) | 4.9 | $14M | 53k | 267.04 | |
| Baxter International (BAX) | 4.7 | $14M | 318k | 42.74 | |
| Merus N V (MRUS) | 4.5 | $13M | 286k | 45.03 | |
| Tandem Diabetes Care Com New (TNDM) | 4.0 | $12M | 327k | 35.41 | |
| Argenx Se Sponsored Adr (ARGX) | 3.8 | $11M | 28k | 393.72 | |
| Xenon Pharmaceuticals (XENE) | 3.1 | $8.9M | 208k | 43.05 | |
| Regeneron Pharmaceuticals (REGN) | 2.9 | $8.2M | 8.6k | 962.49 | |
| Axsome Therapeutics (AXSM) | 2.8 | $8.2M | 103k | 79.80 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.3 | $6.5M | 107k | 61.02 | |
| EXACT Sciences Corporation (EXAS) | 2.2 | $6.2M | 90k | 69.06 | |
| Lyra Therapeutics | 2.1 | $6.1M | 979k | 6.22 | |
| Astria Therapeutics (ATXS) | 1.8 | $5.2M | 370k | 14.07 | |
| Inspire Med Sys (INSP) | 1.8 | $5.1M | 24k | 214.79 | |
| Alpine Immune Sciences | 1.7 | $4.8M | 121k | 39.64 | |
| Arcturus Therapeutics Hldg I (ARCT) | 1.6 | $4.7M | 139k | 33.77 | |
| Arcutis Biotherapeutics (ARQT) | 1.5 | $4.5M | 450k | 9.91 | |
| Mind Medicine Mindmed Com New (MNMD) | 1.2 | $3.6M | 380k | 9.40 | |
| IsoRay | 0.3 | $929k | 780k | 1.19 | |
| Femasys (FEMY) | 0.0 | $47k | 31k | 1.55 |
